Dosage and duration effects of Korean red ginseng intake on frequency of gross deletions in the nef gene

Journal of Ginseng Research

Volumn 34, Issue 3, 2010, Pages 219-226

  Cho, Young Keol ^a   Jung, You Sun ^a  

^a University of Ulsan   (South Korea)

Author keywords

AIDS; Gross deletion; HIV 1; Korean red ginseng; nef

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PANAX GINSENG;

EID: 79951806871     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2010.34.3.219     Document Type: Article

References (37)

1. Huang Y, Zhang L, Ho DD. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 1998;240:36-49. (Pubitemid 28394121)
2. Zhang L, Huang Y, Yuan H, Tuttleton S, Ho DD. Genetic characterization of vif, vpr, and vpu sequences from longterm survivors of human immunodeficiency virus type 1 infection. Virology 1997;228:340-349. (Pubitemid 27238801)
3. Miura T, Brockman MA, Brumme CJ, Brumme ZL, Carlson JM, Pereyra F, Trocha A, Addo MM, Block BL, Rothchild AC, et al. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J Virol 2008;82:8422-8430.
4. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
5. Churchill MJ, Rhodes DI, Learmont JC, Sullivan JS, Wesselingh SL, Cooke IR, Deacon NJ, Gorry PR. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of longterm survivors infected from a single source. J Virol 2006;80:1047-1052. (Pubitemid 43062917)
6. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007;27:406-416. (Pubitemid 47418678)
7. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860. (Pubitemid 28135961)
8. Li CP, Li RC. An introductory note to ginseng. Am J Chin Med (Gard City N Y) 1973;1:249-261.
9. Sakure S, Negi VD, Mitra SK, Nandakumar KS, Chakravortty D. Vaccine with herbal adjuvant-a better cocktail to combat the infection. Vaccine 2008;26:3387-3388.
10. Rivera E, Ekholm PF, Inganas M, Paulie S, Gronvik KO. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005;23:5411-5419. (Pubitemid 41579313)
11. Cho YK, Kim YB, Choi BS, Cho YJ, Suh IS, Shin YH. The increase of T cell by Korean red ginseng in HIV-infected individuals. J Korean Soc Microbiol 1994;29:371-379.
12. Cho YK, Kim YK, Lee I, Choi MH, Shin YO. The effect of Korean red ginseng (KRG), zidovudine (ZDV), and the combination of KRG and ZDV on HIV-infected patients. J Korean Soc Microbiol 1996;31:353-360.
13. Cho YK, Kim YB, Kim YK, Lee HJ, Oh WI. Sequence analysis of C2-V3 region of human immunodeficiency virus type 1 gp120 and its correlation with clinical significance: the effect of long-term intake of Korean red ginseng on env gene variation. J Korean Soc Microbiol 1997;32:611-623.
14. Cho YK, Sung H, Lee HJ, Joo CH, Cho GJ. Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed. Int Immunopharmacol 2001;1:1295-1305. (Pubitemid 32522983)
15. Cho YK, Sung H, Kim TK, Lim JY, Jung YS, Kang SM. Korean red ginseng significantly slows CD4 T cell depletion over 10 years in HIV-1 infected patients: association with HLA. J Ginseng Res 2004;28:173-182. (Pubitemid 40209775)
16. Sung H, Kang SM, Lee MS, Kim TG, Cho YK. Korean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 2005;12:497-501. (Pubitemid 41175316)
17. Cho YK, Sung HS. Effect of Korean red ginseng on serum soluble CD8 in HIV-1-infected patients. J Ginseng Res 2007;31:175-180.
18. Cho YK, Lim JY, Jung YS, Oh SK, Lee HJ, Sung H. High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng. Curr HIV Res 2006;4:447-457. (Pubitemid 44529197)
19. Cho YK, Jung YS, Sung H. Frequent gross deletion in the HIV type 1 nef gene in hemophiliacs treated with Korean Red Ginseng: inhibition of detection by highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2009;25:419-424.
20. Cho YK, Jung YS. High frequency of gross deletions in the 5' LTR and gag regions in HIV type 1-infected longterm survivors treated with Korean red ginseng. AIDS Res Hum Retroviruses 2008;24:181-193.
21. Cho YK, Jung YS, Sung H, Sim MK, Kim YK. High frequency of gross deletions in 5' LTR/gag and nef genes in patients infected with CRF02-AG of HIV type 1 who survived for over 20 years: an association with Korean red ginseng. AIDS Res Hum Retroviruses 2009;25:535-541.
22. Sung H, Jung YS, Cho YK. Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients. Clin Vaccine Immunol 2009;16:1127-1131.
23. Cho YK, Foley BT, Sung H, Kim YB, Kim JH. Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990. Vox Sang 2007;92:113-120. (Pubitemid 46239227)
24. Cho YK, Lee HJ. The detection of ICD p24 antigen predicts bad prognosis in HIV-1 infected patients. J Korean Soc Virol 1996;26:259-267.
25. Scorza SR, Fabio G, Lazzarin A, Eisera NB, Moroni M, Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with humanimmunodeficiency-virus infection. Lancet 1986;2:1187-1189. (Pubitemid 17204889)
26. Itescu S, Mathur-Wagh U, Skovron ML, Brancato LJ, Marmor M, Zeleniuch-Jacquotte A, Winchester R. HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 1992;5:37-45.
27. Wei Y, Ma CM, Hattori M. Anti-HIV protease triterpenoids from the acid hydrolysate of Panax ginseng. Phytochem Lett 2009;2:63-66.
28. Zhang H, Lu Z, Tan GT. Polyacetylenginseng-Ro, a novel triterpene saponin from Panax ginseng. Tetrahedron Lett 2002;43:973-977. (Pubitemid 34126402)
29. Lam SK, Ng TB. A xylanase from roots of sanchi ginseng (Panax notoginseng) with inhibitory effects on human immunodeficiency virus-1 reverse transcriptase. Life Sci 2002;70:3049-3058. (Pubitemid 34442702)
30. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibodydependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997;35:229-235. (Pubitemid 27063822)
31. Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, Jeong G, Song J Y. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol 2006;36:37-45. (Pubitemid 43116390)
32. Nakaya TA, Kita M, Kuriyama H, Iwakura Y, Imanishi J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interferon Cytokine Res 2004;24:93-100. (Pubitemid 38253636)
33. Kim KH, Lee YS, Jung IS, Park SY, Chung HY, Lee IR, Yun YS. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998;64:110-115.
34. Larsen MW, Moser C, Hoiby N, Song Z, Kharazmi A. Ginseng modulates the immune response by induction of interleukin-12 production. APMIS 2004;112:369-373. (Pubitemid 39318192)
35. B-dependent inflammatory responses and protect mice from endotoxin-induced lethal shock. J Ginseng Res 2008;32; 315-323.
36. Jones KA, Kadonaga JT, Luciw PA, Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986;232:755-759. (Pubitemid 16078720)
37. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693. (Pubitemid 29505408)